{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-22-008452","form_type":"8-K","ticker":"TENX","cik":"0000034956","company_name":"TENAX THERAPEUTICS, INC.","filed_at":"2022-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.208088+00:00","generated_at":"2026-06-25T01:25:05.668025+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Two Armistice Capital directors resign from Tenax board; Armistice waives appointment right","bullets":["Steven Boyd and Keith Maher resigned from Tenax board effective June 10, 2022; no disagreement cited.","Boyd and Maher were designees of Armistice Capital Master Fund Ltd., which had right to appoint two directors.","On June 13, 2022, Armistice irrevocably waived its appointment right under the July 2020 Purchase Agreement.","The waiver eliminates Armistice's ability to designate future board members."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-22-008452","json":"https://secwatch.observer/filing/0001654954-22-008452.json","markdown":"https://secwatch.observer/filing/0001654954-22-008452.md","text":"https://secwatch.observer/filing/0001654954-22-008452.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/0001654954-22-008452-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/tenx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:25:05.668025+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"14e401cbfa","claim":"Keith Maher resigned as Director at TENAX THERAPEUTICS, INC..","evidence_excerpt":"On June 10, 2022, Steven Boyd and Keith Maher, MD, both of Armistice Capital, LLC, the investment manager to Armistice Capital Master Fund Ltd. (the “Master Fund”), notified the Board of Directors (the “Board”) of Tenax Therapeutics, Inc. (the “Company”) that they have resigned from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/0001654954-22-008452-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"956ba75714","claim":"Steven Boyd resigned as Director at TENAX THERAPEUTICS, INC..","evidence_excerpt":"On June 10, 2022, Steven Boyd and Keith Maher, MD, both of Armistice Capital, LLC, the investment manager to Armistice Capital Master Fund Ltd. (the “Master Fund”), notified the Board of Directors (the “Board”) of Tenax Therapeutics, Inc. (the “Company”) that they have resigned from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/0001654954-22-008452-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}